We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AUPH market cap is 752.01M. The company's latest EPS is USD -0.5395 and P/E is -9.56.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 29.96M | 34.41M | 44.83M | 54.52M | 45.1M |
Operating Income | -28.75M | -29.58M | -16.46M | -13.62M | -28.98M |
Net Income | -26.05M | -26.21M | -11.49M | -13.45M | -26.88M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 372k | 50.12M | 45.61M | 135.55M | 175.51M |
Operating Income | -85.3M | -104.29M | -180.74M | -111.47M | -91.69M |
Net Income | -123.85M | -102.68M | -180.97M | -108.18M | -78.02M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 470.86M | 451.76M | 548.9M | 555.01M | 548.06M |
Total Liabilities | 65.43M | 61.35M | 156.61M | 163.14M | 170.11M |
Total Equity | 405.44M | 390.41M | 392.29M | 391.88M | 377.95M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 326.68M | 463.66M | 543.37M | 470.86M | 548.06M |
Total Liabilities | 53.17M | 55.91M | 64.28M | 65.43M | 170.11M |
Total Equity | 273.52M | 407.75M | 479.09M | 405.44M | 377.95M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -79.53M | -31.67M | -34.5M | -47.77M | -33.46M |
Investing | -60.63M | 24.86M | 19.25M | -449k | -6.71M |
Financing | 2.43M | 1.64M | 2.78M | 447k | -5.13M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -63.46M | -69.86M | -157.69M | -79.53M | -33.46M |
Investing | 7.78M | -158.19M | -103.87M | -60.63M | -6.71M |
Financing | 243.73M | 194.38M | 221.11M | 2.43M | -5.13M |
Market Cap | 752.01M |
Price to Earnings Ratio | -9.56 |
Price to Sales Ratio | 4.25 |
Price to Cash Ratio | 15.27 |
Price to Book Ratio | 1.97 |
Dividend Yield | - |
Shares Outstanding | 144.62M |
Average Volume (1 week) | 1.34M |
Average Volume (1 Month) | 1.26M |
52 Week Change | -53.61% |
52 Week High | 12.43 |
52 Week Low | 4.71 |
Spread (Intraday) | 0.06 (1.15%) |
Company Name | Aurinia Pharmaceuticals Inc |
Address |
1203-4464 markham street victoria, british columbia V8Z 7X8 |
Website | https://www.auriniapharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions